Insulin glulisine and Tapentadol Extended-Release Tablets
Determining the interaction of Insulin glulisine and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin Glulisine
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine-Tapentadol Hydrochloride
- Insulin glulisine-Tapentadol Tablets
- Insulin glulisine-TaperDex 12-day
- Insulin glulisine-TaperDex 6-day
- Insulin glulisine-TaperDex 7-day
- Insulin glulisine-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Insulin Glulisine (Cartridges and Pens)
- Tapentadol Extended-Release Tablets-Insulin Glulisine (Vials)
- Tapentadol Extended-Release Tablets-Insulin glulisine Subcutaneous
- Tapentadol Extended-Release Tablets-Insulin human inhaled Inhalation
- Tapentadol Extended-Release Tablets-Insulin human regular Injection
- Tapentadol Extended-Release Tablets-Insulin inhalation